Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 20.34M P/E - EPS this Y 28.20% Ern Qtrly Grth -
Income -17.87M Forward P/E -0.64 EPS next Y 8.90% 50D Avg Chg -5.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -52.00%
Dividend N/A Price/Book 2.08 EPS next 5Y - 52W High Chg -81.00%
Recommedations 1.50 Quick Ratio 3.77 Shares Outstanding 32.56M 52W Low Chg 15.00%
Insider Own 10.03% ROA -94.77% Shares Float 24.03M Beta -3.82
Inst Own 40.77% ROE -182.61% Shares Shorted/Prior 865.27K/193.36K Price 0.96
Gross Margin - Profit Margin - Avg. Volume 64,045 Target Price 5.75
Oper. Margin - Earnings Date Nov 11 Volume 3,413 Change 0.48%
About Modular Medical, Inc.

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

Modular Medical, Inc. News
04:05 PM Modular Medical Announces Proposed Public Offering
11/11/24 Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
11/08/24 Registration Is Now Open For Tribe Public's Webinar Event "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing" Featuring Modular Medical CEO On Monday, November 11, 2024
11/07/24 Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
10/31/24 New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"
10/28/24 New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)
09/30/24 Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
09/18/24 Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
09/11/24 Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
09/09/24 Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024
09/04/24 Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
09/04/24 Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
08/08/24 Registration is Now Open for Tribe Public’s Webinar Event "Diabetes Care Innovator Modular Medical Takes Next Steps" Featuring Modular Medical CEO on Friday, August 9, 2024
08/07/24 Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize
07/15/24 Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform
07/02/24 Here's Why We're A Bit Worried About Modular Medical's (NASDAQ:MODD) Cash Burn Situation
06/03/24 Modular Medical Announces Addition to the Russell Microcap(R) Index
05/22/24 Pleasing Signs As A Number Of Insiders Buy Modular Medical Stock
02:01 PM Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30
03/26/24 Modular Medical Announces Steve Gemmell as New Vice President of Engineering
MODD Chatroom

User Image LLYW Posted - 43 minutes from now

$MODD my luck bought in today at $2 lol Likley will add on the way down . Easy 1.20-1.40s

User Image mdorcelsius Posted - 46 minutes ago

$MODD you could also say it just filled in the gap from early Sept., just needs to hold the $1.95 support.

User Image Paladin12 Posted - 1 hour ago

$MODD Not looking good at all every day dropping.

User Image LoveFest24 Posted - 1 hour ago

$MODD this is gonna retest lows with the coming ER's because it will take years to establish a customer base just like it did for $TNDM who just recently showed a path to profit after years of blowing through cash. They might have a good ER in 5 years, best case scenario is they sell them at cost, get a loyal fan base going using the free loop app and use their popularity to become a big enough problem for $DXCM to force them to buy them out. IMO

User Image jheerdink Posted - 6 days ago

$MODD world diabetes day nov 14 $TNDM https://www.linkedin.com/posts/modular-medical_worlddiabetesday-diabeteslife-activity-7262947189843210241-55xz?utm_source=share&utm_medium=member_ios

User Image jheerdink Posted - 1 week ago

$MODD "We are very pleased and proud to be a sponsor of this important new conference," said Jeb Besser, CEO of Modular Medical. "The conference mission aligns closely with our corporate vision to revolutionize patient access by enabling rapid uptake of important diabetes technology for the people with insulin-requiring diabetes who might benefit most. We look forward to meeting key stakeholders and sharing details on our debut insulin pump, the MODD1, and our plans to bring it to market," Mr. Besser added. $PODD $MDT https://finance.yahoo.com/news/modular-medical-proudly-sponsors-inaugural-130000967.html

User Image VerbMan Posted - 1 week ago

$MODD Update to below, I now own a flat 1K shares and plan to take that up to 5K soon once my limit price is hit. Any advice on the buy limit price to set that at?

User Image jheerdink Posted - 1 week ago

$MODD https://www.linkedin.com/posts/modular-medical_modular-medical-supports-the-adept-health-activity-7261896736003022848-VUxX?utm_source=share&utm_medium=member_ios

User Image jheerdink Posted - 1 week ago

$MODD On with Jeb Besser CEO of Modular Medical Now-- Ask you Questions MODDNOV1124.TribePublic.com $LLY $NVO

User Image Zamasu_ Posted - 1 week ago

$FCEL $MODD $PALI $SUGP She knows what she’s talking about! Beautiful and smart

User Image jheerdink Posted - 1 week ago

$MODD "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing." The event is scheduled to begin at 8:00am pacific/11:00am eastern on Monday, November 11, 2024. To register to join the complimentary event, please visit Tribe Public LLC at MODDNOV1124.TribePublic.com https://finance.yahoo.com/news/registration-now-open-tribe-publics-130000912.html $NVO $LLY Meet with Modular Medical CEO, Jeb Besser Obesity is linked to 30% to 53% of new diabetes cases in the U.S. every year, per research in the Journal of the American Heart Association About half of all patients prescribed a GLP-1 drug for weight loss discontinued after the first 12 weeks, with approximately 30% discontinuing in the first four weeks Discover Modular Medical's Recently Announced Results from a Successful GLP-1 Proof of Concept Study

User Image jheerdink Posted - 2 weeks ago

$MODD "Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days, a 25% improvement over GLP-1 delivered as basal alone -Findings suggest that pump delivery may be a viable approach to achieve GLP-1 weight and blood glucose benefits that are comparable with current treatment standards, either as initial treatment or for maintenance, while bringing personalized dosing flexibility" https://finance.yahoo.com/news/modular-medical-announces-results-successful-130000861.html $LLY

User Image BellaDante5 Posted - 2 weeks ago

$MODD $HIMS

User Image BellaDante5 Posted - 2 weeks ago

$MODD can we see 15-20 % today please!!

User Image BellaDante5 Posted - 2 weeks ago

$MODD what happened??

User Image jheerdink Posted - 2 weeks ago

$MODD

User Image BellaDante5 Posted - 2 weeks ago

$MODD wake up!!!!!

User Image VerbMan Posted - 10/31/24

$MODD Ok, so I tried to buy 10k shares in my 401k, and there was a maximum allowed, so had to put in order for only 3k shares. Guess what, only 106 filled, so I guess I am officially in boys. Can't wait for it to go to $5 to collect my $300 massive gain - ha

User Image jheerdink Posted - 10/29/24

$MODD Check out this job at Modular Medical, Inc.: Senior Manufacturing Process Engineer https://www.linkedin.com/jobs/view/4060802004

User Image VerbMan Posted - 10/24/24

$MODD Wow, I am really impressed with how many comments and action this stock gets here (sarcasm). At DJT stock, so many entries you can't even read them as they're posted, definitely not that issue here!

User Image jheerdink Posted - 10/24/24

$MODD Here's Jeb Besser CEO of Modular Medical currently presenting at a Tribe Public CEO Presentation and Q&A Luncheon Event in North Dallas Today! Join him at future events in your Tribe City across the US! www.tribepublic.com $PODD

User Image jheerdink Posted - 10/22/24

$MODD $TNDM https://www.linkedin.com/posts/modular-medical_teamwork-diabetes-modularmedical-activity-7242929562903310336-T3cK?utm_source=share&utm_medium=member_ios

User Image GoGetIT0 Posted - 1 month ago

$MODD 😔👇 hey dink... How many times does FINRA need to come shut down your companies before they finally put you away for good? Again, you bring no value to this industry... Shocked you have a license and it's time for you to get off the message boards. ** WARNING ALL, John Heerdink has been investigated on numerous occasions for security fraud. He shut down shop and starts again elsewhere. Over the last year we have seen companies in a state of desperation use him to drive stock price. The problem has been, everything he touches ends up crumbling. Beware!

User Image jheerdink Posted - 1 month ago

$MODD "The issuance of this patent and the associated claims represent a major step in our efforts to protect the intellectual property in the MODD1 pump platform," stated Jeb Besser, CEO of Modular Medical. "Some of the key features of our novel, low-cost and accurate insulin delivery technology are now protected by this important issued U.S. patent, which we believe represents a significant new barrier to entry. Our eight families of patents around our pump are an important part of our strategic value and market positioning, and we look forward to announcing further issuances on our portfolio in the future."

User Image SmartContent Posted - 1 month ago

INMB Strong upside as Alzheimer’s and cancer therapies show promise with buy ratings from analysts. UGRO Expanding into new sectors with major contracts, including P.F. Chang’s and municipal projects. LFMD Telehealth and weight management programs continue to drive growth with high demand for GLP-1 treatments. GNSS Securing critical emergency communication contracts, bolstering leadership in public safety technology. OSS Strengthening defense contracts with rugged AI computing solutions for military applications. $MODD FDA-approved insulin pump MODD1 is well-positioned to capture growing diabetes market share. $STTK Insider buying signals confidence as the company shifts focus to autoimmune therapies post-restructuring. $LFCR Scaling contract development with multimillion-dollar deals and expanded production capacity.

User Image SmartContent Posted - 1 month ago

$OSS The defense sector has reliable, long-term demand, and their contracts with the U.S. Special Operations Command for rugged AI solutions place them in a stable, high-growth area. Government contracts provide a strong revenue base, and AI has increasing applicability across sectors. $MODD FDA clearance for the MODD1 insulin pump is a significant milestone, and the personalized metabolic therapy space is growing. Early movers in FDA-approved medical devices can see strong returns as they penetrate the market. $GNSS global contracts for emergency response systems offer consistent growth and strong demand in niche markets. Their contract security and international reach make them a good balance of growth and stability. $LNSR leads in ophthalmic devices, especially with over a million cataract procedures.

User Image totally_possible Posted - 1 month ago

$MODD gap fill at 1.96, can't help but think this company is on an upward trajectory though and is worth way more than $2/sh

User Image SmartContent Posted - 1 month ago

>$5 worth a look: $STTK Insider buying signals confidence, SL-325 autoimmune therapy. $UGRO Secured 12M in new cannabis contracts, positioning for strong growth with potential Florida market expansion​. $MODD FDA clearance of the MODD1 insulin pump sets the stage for growth in personalized metabolic therapy. $ASRV Maintains dividends and focuses on regional growth. $OSS Strengthened its defense sector presence with a contract from US S.O. Command for rugged AI solutions. PHX is benefiting from record royalty volumes and a significant dividend increase. GNSS continues to expand globally, securing critical contracts for its advanced emergency response systems. DALN is driving innovation with a new voter engagement tool for the 2024 election, enhancing digital reach. LNSR leads in ophthalmic devices, having surpassed one million cataract procedures with its cutting-edge laser systems. LFMD is expanding telehealth offerings, especially in weight management, with rising demand for GLP-1 therapies.

User Image is26854 Posted - 1 month ago

$MODD Any board members have thoughts on cash burn in the leadup to the first sales? The medium term rewards seem potentially very large here, but I wonder about rocky share price in the leadup to reports on first sales, and it's difficult for me to ignore short term losses. Then again, I've seen huge unexpected leaps ahead of anticipation and regretted not going for an obvious medium term value. What do others think/expect in the coming 6 months?

User Image jheerdink Posted - 1 month ago

$MODD Watch the Today In Nashville Interview Segment that aired today Oct. 1 "New Tools for Treating #Diabetes by Modular Medical" https://wsmv.com/video/2024/10/01/new-tools-treating-diabetes-by-modular-medical/… FDA cleared MODD1 #insulinpump $MDT $ABT

Analyst Ratings
Benchmark Speculative Buy Mar 21, 24
Oppenheimer Outperform Sep 19, 23
Benchmark Speculative Buy Jun 30, 23
Oppenheimer Outperform May 19, 23
Benchmark Speculative Buy Jan 30, 23
Lake Street Buy Apr 8, 22
Benchmark Speculative Buy Mar 25, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sheibley Philip Brent Director Director Nov 01 Buy 1.29 10,000 12,900 46,139 11/01/23
MANCHESTER MANAGEMENT CO LLC - - Oct 16 Buy 1.07 33,000 35,310 144,750 10/18/23
FRANK MORGAN C. Director Director Aug 30 Buy 1.06 145,949 154,706 206,226 09/01/23
Sheibley Philip Brent Director Director Jul 26 Buy 4.12 2,000 8,240 10,139 08/03/22
MANCHESTER MANAGEMENT CO LLC - - Feb 10 Buy 6.00 300,000 1,800,000 1,983,803 02/14/22
MANCHESTER MANAGEMENT CO LLC - - Jun 30 Buy 2.87 174,215 499,997 304,562 10/29/21
MANCHESTER MANAGEMENT CO LLC 10% Owner 10% Owner Nov 20 Buy 2.25 720,000 1,620,000 917,576 10/29/21